The deal was slammed by Connecticut Attorney General William Tong, who is suing Purdue Pharma in state court.
Connecticut and the other dissenting states said talks with Purdue are progressing so they consented to extend a new, temporary halt to the lawsuits.
“Purdue is not entitled to enter bankruptcy as a means to evade responsibility for the suffering and death they have inflicted on our country,” said Connecticut Attorney General William Tong.
Some Connecticut cities and towns may still prefer to accept Purdue Pharma’s offer to settle suits stemming from the nation’s opioid crisis, even though Connecticut and some other states have rejected it.
Attorney General William Tong said the tentative settlement does not do enough to atone for the havoc wrecked by the opioid epidemic in Connecticut and across the nation.
Conn. Attorney General William Tong is participating in talks with Purdue Pharma, and its owners, the Sackler family, about their offer to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion.
The amended lawsuit says Purdue and the Sacklers told doctors addiction was “not caused by drugs,” but instead was the result of “susceptible individuals.”
Sealed court documents show that a member of the Sackler family, which controls Stamford-based Purdue Pharma, agreed that the company should allow doctors to believe OxyContin was weaker than morphine.
While it’s taken a different legal approach, Connecticut joins Massachusetts in laying the blame for the nation’s opioid crisis on the wealthy Sackler family.
Connecticut became the latest state on Thursday to sue Stamford-based Purdue Pharma, saying the company purposefully downplayed the risks of addiction of OxyContin and other opioid painkillers. Connecticut Attorney General George Jepsen said he sued in Superior Court because Purdue was not “serious about addressing the states’ very real allegations of misconduct and coming to a meaningful settlement.”
WASHINGTON — Nearly two dozen Connecticut cities and towns are scheduled to soon confront Purdue Phama and other opioid makers in court over what they say are the pharmaceuticals’ deceptive practices. Meanwhile, there is an effort by a federal judge in Ohio to negotiate a massive settlement for the hundreds of federal lawsuits across the nation targeting the opioid makers for their marketing practices.
Updated at 10:15 a.m. with industry comment
WASHINGTON — Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of suits by states, counties and cities alleging it is partly to blame for the nation’s opioid epidemic. The lawsuits are all different and some include other pharmaceutical companies and pharmacies as defendants. But Purdue is nearly always a main defendant.